Saturday 17 October 2026
Export AORT’s income statement to Excel — free account
Artivion, Inc.
AORT Healthcare Medical Devices
Artivion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $441.3 million, up 13.6% from fiscal 2024. In the quarter to June 2026, revenue grew 11.3%, EPS fell 1,033.3%, free cash flow fell 202.5% and total debt rose 67.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
21.78
0.09
−0.41%
Follow AORT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
57.58 | 173.64 | 0.00 | 583.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 217.19 |
Piotroski F-Score |
5 | 4 | 5 | 7 | 3 | 5 | 2 | 5 | 4 | 7 |
P/S ratio |
3.36 | 3.32 | 3.93 | 3.64 | 3.53 | 2.65 | 1.50 | 2.07 | 3.07 | 4.69 |
Altman Z-Score |
4.81 | 1.95 | 3.00 | 2.80 | 1.80 | 1.69 | 1.33 | 1.58 | 2.28 | 3.73 |
P/FCF ratio |
44.76 | 151.15 | 252.35 | 129.66 | 177.33 | 0.00 | 0.00 | 141.35 | 166.60 | 0.00 |
Altman Z″-Score (non-manufacturers) |
5.29 | 2.75 | 2.95 | 2.86 | 2.30 | 2.40 | 2.30 | 2.28 | 2.50 | 3.05 |
Beneish M-Score |
(2.93) | (1.91) | (2.53) | (2.50) | (2.79) | (2.40) | (2.38) | (2.76) | (2.54) | (2.38) |
P/Operating CF |
119.97 | 105.48 | 54.85 | 948.61 | 164.02 | 1,107.97 | (2,171.32) | 67.52 | 117.52 | 105.71 |
P/B ratio |
2.90 | 2.28 | 3.76 | 3.52 | 2.72 | 2.64 | 1.66 | 2.60 | 4.31 | 4.61 |
Price to Tangible BV |
9.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54.93 |
EV/Sales |
3.43 | 4.30 | 4.62 | 4.32 | 4.46 | 3.52 | 2.37 | 2.78 | 3.75 | 5.03 |
EV/EBITDA |
20.51 | 46.04 | 44.29 | 33.72 | 48.76 | 32.77 | 25.96 | 34.12 | 23.07 | 39.51 |
EV/Operating CF |
31.42 | 75.49 | 122.86 | 75.34 | 91.27 | (406.88) | (144.30) | 52.23 | 65.44 | 55.68 |
EV/FCF |
45.82 | 195.52 | 296.45 | 153.76 | 223.94 | (58.43) | (38.32) | 189.92 | 203.47 | (726.43) |
Quick Ratio |
2.90 | 2.15 | 2.71 | 1.99 | 1.83 | 2.52 | 2.19 | 2.30 | 2.09 | 1.66 |
Current Ratio |
4.89 | 4.18 | 5.19 | 4.15 | 3.88 | 5.51 | 4.98 | 4.85 | 4.34 | 3.53 |
Net Debt/EBITDA |
0.47 | 10.45 | 6.59 | 5.28 | 10.15 | 8.05 | 9.51 | 8.73 | 4.18 | 2.72 |
Debt/Assets |
22.64% | 38.29% | 39.02% | 36.51% | 37.62% | 39.53% | 40.87% | 39.17% | 40.20% | 24.62% |
Debt/Equity |
0.34 | 0.82 | 0.81 | 0.77 | 0.90 | 1.04 | 1.10 | 1.10 | 1.15 | 0.49 |
Asset Turnover |
0.73 | 0.42 | 0.45 | 0.47 | 0.36 | 0.38 | 0.40 | 0.46 | 0.49 | 0.53 |
Operating CF/Net income |
1.87 | 2.97 | (3.51) | 9.27 | (0.75) | 0.18 | 0.27 | (0.62) | (1.67) | 4.09 |
Capex/Depreciation |
(0.74) | (0.68) | (0.32) | (0.44) | (0.41) | (0.59) | (0.55) | (0.42) | (0.46) | (1.74) |
Interest Coverage |
7.17 | 1.63 | 0.59 | 1.14 | 0.15 | 0.48 | 0.34 | 0.23 | 1.13 | 1.27 |
| 5.80% | 1.50% | (1.02%) | 0.61% | (5.39%) | (4.68%) | (6.53%) | (10.80%) | (4.78%) | 2.69% | |
| 4.25% | 0.80% | (0.48%) | 0.29% | (2.38%) | (1.86%) | (2.45%) | (3.93%) | (1.69%) | 1.17% | |
ROIC |
6.11% | 1.08% | 1.28% | 2.25% | 0.27% | 0.91% | 0.70% | 0.67% | 4.50% | 3.51% |
Return on Tangible Assets |
7.79% | 2.14% | (1.60%) | 0.98% | (8.00%) | (6.13%) | (8.08%) | (11.70%) | (5.14%) | 3.03% |
Average Days of Receivables |
60.90 | 98.98 | 71.42 | 73.81 | 70.27 | 70.97 | 80.94 | 76.44 | 80.69 | 85.75 |
Research and Development Expense of Revenue |
7.45% | 10.26% | 8.79% | 8.31% | 9.56% | 11.89% | 12.39% | 8.11% | 7.32% | 7.02% |
Selling, General and Administrative Expense of Revenue |
50.75% | 53.35% | 53.48% | 51.77% | 55.73% | 56.81% | 50.17% | 59.03% | 46.70% | 51.32% |
Intangible Assets out of Total Assets |
0.46 | 0.62 | 0.61 | 0.57 | 0.62 | 0.57 | 0.56 | 0.53 | 0.50 | 0.46 |
Share Based Compensation of Revenue |
3.51% | 3.65% | 2.41% | 3.19% | 2.73% | 3.58% | 3.93% | 4.07% | 3.67% | 5.53% |
Graham Net Nets |
0.07 | (0.21) | (0.11) | (0.13) | (0.25) | (0.31) | (0.49) | (0.31) | (0.19) | (0.04) |
Graham Number |
6.98 | 4.56 | 0.00 | 2.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.84 |
Earnings Yield |
1.74% | 0.58% | (0.29%) | 0.17% | (1.91%) | (1.87%) | (4.08%) | (4.18%) | (1.08%) | 0.46% |
Free Cash Flow Yield |
2.23% | 0.66% | 0.40% | 0.77% | 0.56% | (2.27%) | (4.12%) | 0.71% | 0.60% | (0.15%) |
Revenue per Share |
5.66 | 5.75 | 7.22 | 7.44 | 6.69 | 7.67 | 7.84 | 8.69 | 9.32 | 9.73 |
Operating CF per Share |
0.62 | 0.33 | 0.27 | 0.43 | 0.33 | (0.07) | (0.13) | 0.46 | 0.53 | 0.88 |
Capex per Share |
(0.19) | (0.20) | (0.16) | (0.22) | (0.22) | (0.36) | (0.31) | (0.24) | (0.27) | (0.86) |
Free Cash Flow per Share |
0.42 | 0.13 | 0.11 | 0.21 | 0.10 | (0.43) | (0.44) | 0.22 | 0.27 | 0.02 |
Cash per Share |
1.80 | 1.23 | 1.16 | 0.92 | 1.64 | 1.41 | 0.98 | 1.45 | 1.28 | 1.43 |
Shareholders Equity per Share |
6.56 | 8.39 | 7.55 | 7.70 | 8.68 | 7.71 | 7.10 | 6.92 | 6.63 | 9.89 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.56 | 8.39 | 7.55 | 7.70 | 8.68 | 7.71 | 7.10 | 6.92 | 6.63 | 9.89 |
Free Cash Flow |
13.52 | 4.17 | 4.10 | 7.76 | 3.88 | (16.65) | (17.57) | 9.07 | 11.05 | 0.84 |
Working Capital |
117.13 | 136.34 | 144.65 | 142.20 | 174.12 | 202.74 | 197.66 | 222.81 | 223.26 | 256.53 |
Capital Expenditures |
(6.20) | (6.63) | (5.79) | (8.07) | (8.48) | (14.06) | (12.41) | (9.75) | (11.19) | (39.04) |
Net Current Asset Value |
40.08 | (133.35) | (116.86) | (132.57) | (226.10) | (244.63) | (231.13) | (229.95) | (222.82) | (78.48) |
EV/EBIT |
28.39 | 102.32 | 130.36 | 69.97 | 462.48 | 129.58 | 119.91 | 171.23 | 37.43 | 65.81 |
Capex to Sales |
0.03 | 0.04 | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 | 0.09 |
Price to Operating Income |
27.74 | 79.10 | 110.97 | 59.00 | 366.20 | 97.73 | 75.98 | 127.44 | 30.65 | 61.28 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.45 | 0.29 | 0.58 | 0.57 | 0.63 | 0.64 | 0.58 | 0.60 | 0.66 | 0.35 |
Cash ROIC |
4.00% | 0.77% | 0.76% | 1.43% | 0.56% | (2.49%) | (2.76%) | 1.39% | 1.71% | 0.11% |
Accounts Receivable Turnover |
6.36 | 4.65 | 5.11 | 5.15 | 4.84 | 5.59 | 4.91 | 4.93 | 4.86 | 4.66 |
Accounts Payable Turnover |
11.90 | 7.87 | 10.38 | 10.75 | 8.80 | 10.12 | 9.93 | 9.86 | 8.93 | 9.24 |
Inventory Turnover |
3.00 | 1.67 | 1.95 | 1.89 | 1.36 | 1.35 | 1.47 | 1.60 | 1.73 | 1.82 |
Average Days of Payables |
34.10 | 58.38 | 30.66 | 38.36 | 41.11 | 37.45 | 39.38 | 38.94 | 46.93 | 37.27 |
Days of Inventory on Hand |
156.10 | 279.06 | 184.73 | 207.82 | 312.01 | 277.28 | 244.32 | 239.70 | 208.32 | 214.74 |
Average Receivables |
28.38 | 40.77 | 51.44 | 53.65 | 52.31 | 53.43 | 63.84 | 71.86 | 80.02 | 94.79 |
Average Payables |
5.17 | 7.76 | 8.66 | 8.67 | 9.71 | 10.01 | 11.20 | 12.66 | 15.64 | 17.01 |
Average Inventory |
20.47 | 36.49 | 46.08 | 49.27 | 63.05 | 75.00 | 75.72 | 78.23 | 80.87 | 86.10 |
Average Assets |
248.66 | 452.92 | 580.39 | 588.37 | 697.53 | 791.23 | 777.93 | 777.60 | 790.75 | 836.95 |
Average Common Equity |
182.12 | 243.02 | 276.06 | 280.38 | 307.20 | 314.72 | 292.53 | 283.05 | 278.99 | 362.22 |
Columns are period end dates